Detalhe da pesquisa
1.
The BTLA-HVEM axis restricts CAR T cell efficacy in cancer.
Nat Immunol
; 25(6): 1020-1032, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38831106
2.
Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.
Cell
; 173(6): 1439-1453.e19, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856956
3.
Encyclopedia of bacterial gene circuits whose presence or absence correlate with pathogenicity--a large-scale system analysis of decoded bacterial genomes.
BMC Genomics
; 16: 773, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26459834
4.
Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function.
Mol Ther Oncol
; 32(2): 200819, 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38912091
5.
Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia.
Blood Adv
; 6(21): 5774-5785, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349631
6.
Human chimeric antigen receptor macrophages for cancer immunotherapy.
Nat Biotechnol
; 38(8): 947-953, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361713
7.
A heuristic method for simulating open-data of arbitrary complexity that can be used to compare and evaluate machine learning methods.
Pac Symp Biocomput
; 23: 259-267, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218887